GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Crem
|
ENSRNOG00000014900 | cAMP responsive element modulator |
Jdp2
|
ENSRNOG00000008224 | Jun dimerization protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Crem | rn6_v1_chr17_+_57031766_57031766 | -0.56 | 4.6e-28 | Click! |
Jdp2 | rn6_v1_chr6_+_109466060_109466060 | 0.39 | 4.1e-13 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_189629297 | 72.70 |
ENSRNOT00000049810
|
Dennd4b
|
DENN domain containing 4B |
chr1_-_220467159 | 61.52 |
ENSRNOT00000075365
|
Tmem151a
|
transmembrane protein 151A |
chr1_+_177495782 | 55.28 |
ENSRNOT00000021020
|
Tead1
|
TEA domain transcription factor 1 |
chr1_+_162768156 | 54.82 |
ENSRNOT00000049321
|
Pak1
|
p21 (RAC1) activated kinase 1 |
chr11_-_62451149 | 53.68 |
ENSRNOT00000093686
ENSRNOT00000081443 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr9_-_78969013 | 50.71 |
ENSRNOT00000019772
ENSRNOT00000057585 |
Fn1
|
fibronectin 1 |
chr17_+_10463303 | 49.13 |
ENSRNOT00000060822
|
Rnf44
|
ring finger protein 44 |
chr3_+_125428260 | 49.08 |
ENSRNOT00000028892
|
Chgb
|
chromogranin B |
chr16_+_72401887 | 47.67 |
ENSRNOT00000074449
|
LOC100910163
|
uncharacterized LOC100910163 |
chr16_+_72388880 | 43.72 |
ENSRNOT00000072459
|
LOC684871
|
similar to Protein C8orf4 (Thyroid cancer protein 1) (TC-1) |
chr10_+_16970626 | 42.81 |
ENSRNOT00000005383
|
Dusp1
|
dual specificity phosphatase 1 |
chr4_-_57625147 | 39.02 |
ENSRNOT00000074649
ENSRNOT00000078961 |
Ube2h
|
ubiquitin-conjugating enzyme E2H |
chr5_+_159845774 | 38.78 |
ENSRNOT00000012328
|
Epha2
|
Eph receptor A2 |
chr1_+_81395841 | 38.10 |
ENSRNOT00000072750
|
Irgq
|
immunity-related GTPase Q |
chr10_-_65424802 | 36.82 |
ENSRNOT00000018468
|
Traf4
|
Tnf receptor associated factor 4 |
chr18_-_28017925 | 35.77 |
ENSRNOT00000075420
|
Lrrtm2
|
leucine rich repeat transmembrane neuronal 2 |
chr9_-_43276685 | 34.11 |
ENSRNOT00000022779
|
Actr1b
|
ARP1 actin-related protein 1 homolog B, centractin beta |
chr10_+_11724032 | 33.72 |
ENSRNOT00000008966
|
Trap1
|
TNF receptor-associated protein 1 |
chr9_-_85243001 | 32.42 |
ENSRNOT00000020219
|
Scg2
|
secretogranin II |
chr13_-_50916982 | 32.25 |
ENSRNOT00000004408
|
Btg2
|
BTG anti-proliferation factor 2 |
chr16_-_50501921 | 30.76 |
ENSRNOT00000081023
|
Fat1
|
FAT atypical cadherin 1 |
chr16_-_50501716 | 30.50 |
ENSRNOT00000067486
|
Fat1
|
FAT atypical cadherin 1 |
chr16_-_74122889 | 30.46 |
ENSRNOT00000025763
|
Plat
|
plasminogen activator, tissue type |
chr12_-_13668515 | 30.38 |
ENSRNOT00000086847
|
Fscn1
|
fascin actin-bundling protein 1 |
chr12_+_47920743 | 29.96 |
ENSRNOT00000072511
|
Mmab
|
methylmalonic aciduria (cobalamin deficiency) cblB type |
chr6_+_129399468 | 27.22 |
ENSRNOT00000071735
ENSRNOT00000074621 |
Bdkrb2
|
bradykinin receptor B2 |
chr4_-_157078130 | 26.82 |
ENSRNOT00000015570
|
Clstn3
|
calsyntenin 3 |
chr20_-_10257044 | 25.85 |
ENSRNOT00000068289
|
Wdr4
|
WD repeat domain 4 |
chr17_+_31493107 | 24.67 |
ENSRNOT00000023611
ENSRNOT00000086264 |
Tubb2a
|
tubulin, beta 2A class IIa |
chr12_+_17416327 | 24.58 |
ENSRNOT00000089590
ENSRNOT00000092186 |
Adap1
|
ArfGAP with dual PH domains 1 |
chr15_+_43007908 | 24.06 |
ENSRNOT00000084753
ENSRNOT00000091567 ENSRNOT00000087709 |
Stmn4
|
stathmin 4 |
chr9_+_82370924 | 23.98 |
ENSRNOT00000025219
|
Zfand2b
|
zinc finger AN1-type containing 2B |
chrX_+_151103576 | 23.87 |
ENSRNOT00000015401
|
Slitrk2
|
SLIT and NTRK-like family, member 2 |
chr10_-_64398294 | 23.71 |
ENSRNOT00000010386
|
Glod4
|
glyoxalase domain containing 4 |
chr3_+_8802852 | 23.16 |
ENSRNOT00000033934
|
Lrrc8a
|
leucine rich repeat containing 8 family, member A |
chr8_+_69127708 | 22.80 |
ENSRNOT00000013490
|
Snapc5
|
small nuclear RNA activating complex, polypeptide 5 |
chr15_+_57290849 | 22.51 |
ENSRNOT00000014909
|
Cpb2
|
carboxypeptidase B2 |
chr6_+_126434226 | 22.31 |
ENSRNOT00000090857
|
Chga
|
chromogranin A |
chr1_+_157573324 | 22.31 |
ENSRNOT00000092066
|
Rab30
|
RAB30, member RAS oncogene family |
chr3_-_120011364 | 22.25 |
ENSRNOT00000018922
|
Fahd2a
|
fumarylacetoacetate hydrolase domain containing 2A |
chr2_-_185005572 | 22.04 |
ENSRNOT00000093291
|
Fam160a1
|
family with sequence similarity 160, member A1 |
chr8_-_57255263 | 21.59 |
ENSRNOT00000028972
|
LOC100125362
|
hypothetical protein LOC100125362 |
chr10_+_102136283 | 21.42 |
ENSRNOT00000003735
|
Sstr2
|
somatostatin receptor 2 |
chrX_+_1321315 | 21.23 |
ENSRNOT00000014250
|
Syn1
|
synapsin I |
chr4_+_163293724 | 21.19 |
ENSRNOT00000077356
|
Gabarapl1
|
GABA type A receptor associated protein like 1 |
chr19_-_43841795 | 21.03 |
ENSRNOT00000079539
|
Ldhd
|
lactate dehydrogenase D |
chr8_+_44136496 | 20.77 |
ENSRNOT00000087022
|
Scn3b
|
sodium voltage-gated channel beta subunit 3 |
chr11_-_38457373 | 20.77 |
ENSRNOT00000041177
|
Zfp295
|
zinc finger protein 295 |
chr17_+_57074525 | 20.33 |
ENSRNOT00000020012
ENSRNOT00000074146 |
Crem
|
cAMP responsive element modulator |
chr2_-_187909394 | 20.19 |
ENSRNOT00000032355
|
Rab25
|
RAB25, member RAS oncogene family |
chr20_-_10680283 | 19.79 |
ENSRNOT00000001579
|
Sik1
|
salt-inducible kinase 1 |
chrX_+_16170576 | 19.57 |
ENSRNOT00000003895
|
Clcn5
|
chloride voltage-gated channel 5 |
chr15_-_109394905 | 19.27 |
ENSRNOT00000019602
ENSRNOT00000078424 |
Tmtc4
|
transmembrane and tetratricopeptide repeat containing 4 |
chr5_-_114014277 | 18.58 |
ENSRNOT00000011731
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit |
chr10_-_37554664 | 18.58 |
ENSRNOT00000007621
|
Ppp2ca
|
protein phosphatase 2 catalytic subunit alpha |
chr9_-_19613360 | 18.44 |
ENSRNOT00000029593
|
Rcan2
|
regulator of calcineurin 2 |
chr1_-_89124132 | 18.36 |
ENSRNOT00000031044
|
Haus5
|
HAUS augmin-like complex, subunit 5 |
chr6_+_72891725 | 18.35 |
ENSRNOT00000038074
|
Nubpl
|
nucleotide binding protein-like |
chr4_-_64981384 | 17.97 |
ENSRNOT00000017338
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr2_-_66608324 | 17.53 |
ENSRNOT00000077597
|
Cln5
|
ceroid-lipofuscinosis, neuronal 5 |
chr7_-_124982566 | 17.52 |
ENSRNOT00000075099
|
Sult4a1
|
sulfotransferase family 4A, member 1 |
chr12_+_37984790 | 17.36 |
ENSRNOT00000001445
|
Vps37b
|
VPS37B, ESCRT-I subunit |
chr4_+_157554794 | 16.83 |
ENSRNOT00000024116
|
Ing4
|
inhibitor of growth family, member 4 |
chr1_+_196996581 | 16.81 |
ENSRNOT00000021690
|
Il21r
|
interleukin 21 receptor |
chr10_-_45514878 | 16.73 |
ENSRNOT00000036940
|
Iba57
|
IBA57 homolog, iron-sulfur cluster assembly |
chr8_-_50246656 | 16.43 |
ENSRNOT00000024240
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr6_-_91456696 | 16.36 |
ENSRNOT00000005577
|
Rps29
|
ribosomal protein S29 |
chr1_+_103172987 | 16.29 |
ENSRNOT00000018688
|
Tmem86a
|
transmembrane protein 86A |
chr4_+_157452607 | 16.27 |
ENSRNOT00000022467
|
Mlf2
|
myeloid leukemia factor 2 |
chr19_-_37990353 | 16.24 |
ENSRNOT00000026817
|
Ddx28
|
DEAD-box helicase 28 |
chr4_+_157453069 | 16.12 |
ENSRNOT00000088622
|
Mlf2
|
myeloid leukemia factor 2 |
chr8_+_114866768 | 16.10 |
ENSRNOT00000076731
|
Wdr82
|
WD repeat domain 82 |
chr3_+_150801289 | 16.10 |
ENSRNOT00000035060
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha |
chr2_+_188784222 | 16.07 |
ENSRNOT00000028095
|
Pmvk
|
phosphomevalonate kinase |
chr17_-_47394231 | 16.05 |
ENSRNOT00000079368
ENSRNOT00000079216 |
Sfrp4
|
secreted frizzled-related protein 4 |
chr10_-_14056169 | 16.04 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chrX_+_158978755 | 15.92 |
ENSRNOT00000066809
|
Slc9a6
|
solute carrier family 9 member A6 |
chr8_+_22021213 | 15.77 |
ENSRNOT00000049706
|
Mrpl4
|
mitochondrial ribosomal protein L4 |
chr2_+_181331464 | 15.71 |
ENSRNOT00000017448
|
Map9
|
microtubule-associated protein 9 |
chr9_+_30939555 | 15.69 |
ENSRNOT00000016887
|
Lmbrd1
|
LMBR1 domain containing 1 |
chr6_+_43829945 | 15.61 |
ENSRNOT00000086548
|
Klf11
|
Kruppel-like factor 11 |
chr8_-_50245838 | 15.53 |
ENSRNOT00000035310
|
Sidt2
|
SID1 transmembrane family, member 2 |
chr5_+_148320438 | 15.42 |
ENSRNOT00000018742
|
Pef1
|
penta-EF hand domain containing 1 |
chr4_-_113866674 | 15.40 |
ENSRNOT00000010020
|
Dok1
|
docking protein 1 |
chrX_-_158978995 | 15.40 |
ENSRNOT00000001179
|
Mmgt1
|
membrane magnesium transporter 1 |
chr5_-_152464850 | 15.23 |
ENSRNOT00000021937
|
Zfp593
|
zinc finger protein 593 |
chr8_-_128009951 | 14.86 |
ENSRNOT00000018056
|
Oxsr1
|
oxidative-stress responsive 1 |
chr8_+_117793289 | 14.82 |
ENSRNOT00000056199
|
Shisa5
|
shisa family member 5 |
chr4_-_6330699 | 14.62 |
ENSRNOT00000078077
ENSRNOT00000011814 |
Galnt11
|
polypeptide N-acetylgalactosaminyltransferase 11 |
chr19_+_31524671 | 14.53 |
ENSRNOT00000024616
|
Hhip
|
Hedgehog-interacting protein |
chr17_-_9695292 | 14.40 |
ENSRNOT00000036162
|
Prr7
|
proline rich 7 (synaptic) |
chr7_+_63922879 | 14.40 |
ENSRNOT00000043581
|
RGD1565498
|
similar to Hypothetical protein LOC270802 |
chr1_-_59732409 | 14.28 |
ENSRNOT00000014824
|
Has1
|
hyaluronan synthase 1 |
chrX_+_45420596 | 14.27 |
ENSRNOT00000051897
|
Sts
|
steroid sulfatase (microsomal), isozyme S |
chr1_-_198382614 | 13.92 |
ENSRNOT00000055016
|
Asphd1
|
aspartate beta-hydroxylase domain containing 1 |
chr8_+_122076759 | 13.76 |
ENSRNOT00000012545
|
Clasp2
|
cytoplasmic linker associated protein 2 |
chr14_-_83062302 | 13.59 |
ENSRNOT00000086769
ENSRNOT00000085735 |
Ywhah
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chrX_+_28593405 | 13.46 |
ENSRNOT00000071708
|
Tmsb4x
|
thymosin beta 4, X-linked |
chr4_+_113866804 | 13.39 |
ENSRNOT00000081196
|
Loxl3
|
lysyl oxidase-like 3 |
chr10_-_13542077 | 13.36 |
ENSRNOT00000008736
|
Atp6v0c
|
ATPase H+ transporting V0 subunit C |
chr1_+_261415191 | 13.26 |
ENSRNOT00000083287
ENSRNOT00000040740 |
Zfyve27
|
zinc finger FYVE-type containing 27 |
chr5_+_36076565 | 13.26 |
ENSRNOT00000013599
|
Faxc
|
failed axon connections homolog |
chr1_-_64090017 | 13.10 |
ENSRNOT00000086622
ENSRNOT00000091654 |
Rps9
|
ribosomal protein S9 |
chr7_-_118332577 | 13.01 |
ENSRNOT00000090370
|
Rbfox2
|
RNA binding protein, fox-1 homolog 2 |
chr4_+_83391283 | 12.98 |
ENSRNOT00000031365
|
Creb5
|
cAMP responsive element binding protein 5 |
chr18_-_51651267 | 12.97 |
ENSRNOT00000020325
|
Aldh7a1
|
aldehyde dehydrogenase 7 family, member A1 |
chr7_+_121311024 | 12.87 |
ENSRNOT00000092260
ENSRNOT00000023066 ENSRNOT00000081377 |
Syngr1
|
synaptogyrin 1 |
chr14_+_63095720 | 12.75 |
ENSRNOT00000006071
|
Ppargc1a
|
PPARG coactivator 1 alpha |
chr14_-_80355420 | 12.74 |
ENSRNOT00000049798
|
Acox3
|
acyl-CoA oxidase 3, pristanoyl |
chrX_-_1346181 | 12.73 |
ENSRNOT00000042736
|
LOC102555453
|
60S ribosomal protein L12-like |
chr14_-_83741969 | 12.73 |
ENSRNOT00000026293
|
Inpp5j
|
inositol polyphosphate-5-phosphatase J |
chr1_+_213870502 | 12.67 |
ENSRNOT00000086483
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr7_-_14435967 | 12.64 |
ENSRNOT00000074801
|
Pglyrp2
|
peptidoglycan recognition protein 2 |
chr10_+_56576428 | 12.49 |
ENSRNOT00000079237
ENSRNOT00000023291 |
Cldn7
|
claudin 7 |
chr2_-_152824547 | 12.37 |
ENSRNOT00000019824
|
Dhx36
|
DEAH-box helicase 36 |
chr17_+_57075218 | 12.31 |
ENSRNOT00000089536
|
Crem
|
cAMP responsive element modulator |
chr10_+_104582955 | 12.29 |
ENSRNOT00000009733
|
Unk
|
unkempt family zinc finger |
chr12_+_13102019 | 12.21 |
ENSRNOT00000092628
|
Rac1
|
ras-related C3 botulinum toxin substrate 1 |
chr8_-_62248013 | 12.20 |
ENSRNOT00000080012
ENSRNOT00000089602 |
Scamp5
|
secretory carrier membrane protein 5 |
chrX_+_15064594 | 12.16 |
ENSRNOT00000007130
|
Tbc1d25
|
TBC1 domain family, member 25 |
chr8_+_48472824 | 12.01 |
ENSRNOT00000010463
ENSRNOT00000090780 |
Mcam
|
melanoma cell adhesion molecule |
chr7_-_58587787 | 11.86 |
ENSRNOT00000005814
|
Lgr5
|
leucine rich repeat containing G protein coupled receptor 5 |
chr10_+_37757146 | 11.76 |
ENSRNOT00000008119
ENSRNOT00000087555 |
RGD1310352
|
similar to HTGN29 protein; keratinocytes associated transmembrane protein 2 |
chr6_-_7741414 | 11.70 |
ENSRNOT00000038246
|
Thada
|
THADA, armadillo repeat containing |
chr4_-_168297373 | 11.67 |
ENSRNOT00000066575
|
Lrp6
|
LDL receptor related protein 6 |
chr10_+_45559578 | 11.63 |
ENSRNOT00000004011
|
RGD1304587
|
similar to RIKEN cDNA 2310033P09 |
chr7_+_12948952 | 11.42 |
ENSRNOT00000010714
|
Shc2
|
SHC adaptor protein 2 |
chr9_+_45672157 | 11.15 |
ENSRNOT00000017882
|
Pdcl3
|
phosducin-like 3 |
chr19_+_56272162 | 11.02 |
ENSRNOT00000030399
|
Afg3l1
|
AFG3(ATPase family gene 3)-like 1 (S. cerevisiae) |
chr1_+_225048149 | 10.98 |
ENSRNOT00000036454
|
Lrrn4cl
|
LRRN4 C-terminal like |
chrX_-_157139291 | 10.96 |
ENSRNOT00000092123
|
Slc6a8
|
solute carrier family 6 member 8 |
chr3_-_15463881 | 10.91 |
ENSRNOT00000009706
|
Rbm18
|
RNA binding motif protein 18 |
chr8_+_114867062 | 10.90 |
ENSRNOT00000074771
|
Wdr82
|
WD repeat domain 82 |
chr9_+_82674202 | 10.88 |
ENSRNOT00000027208
|
Tmem198
|
transmembrane protein 198 |
chr1_-_64021321 | 10.87 |
ENSRNOT00000090819
|
Rps9
|
ribosomal protein S9 |
chr4_+_6330466 | 10.82 |
ENSRNOT00000089582
|
E130116L18Rik
|
RIKEN cDNA E130116L18 gene |
chr3_+_100366168 | 10.82 |
ENSRNOT00000006689
|
Kif18a
|
kinesin family member 18A |
chr1_+_201256910 | 10.76 |
ENSRNOT00000090143
|
Tacc2
|
transforming, acidic coiled-coil containing protein 2 |
chr9_-_99651813 | 10.67 |
ENSRNOT00000022089
|
Ndufa10
|
NADH:ubiquinone oxidoreductase subunit A10 |
chr3_+_161212156 | 10.64 |
ENSRNOT00000020280
ENSRNOT00000083553 |
Dnttip1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr7_-_142180997 | 10.63 |
ENSRNOT00000087632
|
Tfcp2
|
transcription factor CP2 |
chr7_+_25919867 | 10.58 |
ENSRNOT00000009625
ENSRNOT00000090153 |
Ric8b
|
RIC8 guanine nucleotide exchange factor B |
chr12_-_16002788 | 10.56 |
ENSRNOT00000090318
|
Amz1
|
archaelysin family metallopeptidase 1 |
chr1_-_31055453 | 10.42 |
ENSRNOT00000031083
|
Soga3
|
SOGA family member 3 |
chr11_+_80358211 | 10.35 |
ENSRNOT00000002519
|
Sst
|
somatostatin |
chr1_-_182140570 | 10.33 |
ENSRNOT00000060098
|
Ythdc2
|
YTH domain containing 2 |
chr1_-_216080287 | 10.31 |
ENSRNOT00000027682
|
Th
|
tyrosine hydroxylase |
chr14_-_78707861 | 10.24 |
ENSRNOT00000091927
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr1_-_252808380 | 10.24 |
ENSRNOT00000025856
|
Ch25h
|
cholesterol 25-hydroxylase |
chr3_+_140024043 | 10.22 |
ENSRNOT00000086409
|
Rin2
|
Ras and Rab interactor 2 |
chr19_+_37990374 | 10.14 |
ENSRNOT00000026827
|
Dus2
|
dihydrouridine synthase 2 |
chr10_+_70884531 | 10.14 |
ENSRNOT00000015199
|
Ccl4
|
C-C motif chemokine ligand 4 |
chr10_+_64398339 | 10.13 |
ENSRNOT00000056278
|
Mrm3
|
mitochondrial rRNA methyltransferase 3 |
chr10_+_13000090 | 10.04 |
ENSRNOT00000004845
|
Cldn6
|
claudin 6 |
chr1_+_219329574 | 10.04 |
ENSRNOT00000071109
|
Cabp2
|
calcium binding protein 2 |
chr18_-_16497886 | 9.96 |
ENSRNOT00000021624
|
Rprd1a
|
regulation of nuclear pre-mRNA domain containing 1A |
chr9_-_19476646 | 9.90 |
ENSRNOT00000013703
|
Enpp5
|
ectonucleotide pyrophosphatase/phosphodiesterase 5 |
chr19_-_54245855 | 9.74 |
ENSRNOT00000023855
|
Emc8
|
ER membrane protein complex subunit 8 |
chr1_-_156296161 | 9.66 |
ENSRNOT00000025653
|
Crebzf
|
CREB/ATF bZIP transcription factor |
chr4_-_159079003 | 9.66 |
ENSRNOT00000026691
|
Kcna5
|
potassium voltage-gated channel subfamily A member 5 |
chr13_+_110257571 | 9.65 |
ENSRNOT00000005715
|
Ints7
|
integrator complex subunit 7 |
chr7_-_2909144 | 9.65 |
ENSRNOT00000082518
ENSRNOT00000089074 ENSRNOT00000085644 |
Myl6
|
myosin light chain 6 |
chr7_+_141054494 | 9.60 |
ENSRNOT00000088176
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr6_+_26387877 | 9.55 |
ENSRNOT00000076105
|
Fndc4
|
|
chr7_-_2941122 | 9.50 |
ENSRNOT00000082107
|
Esyt1
|
extended synaptotagmin 1 |
chr1_-_80221710 | 9.41 |
ENSRNOT00000091687
|
Fosb
|
FosB proto-oncogene, AP-1 transcription factor subunit |
chr3_+_110442637 | 9.38 |
ENSRNOT00000010471
|
Pak6
|
p21 (RAC1) activated kinase 6 |
chr18_-_77322690 | 9.36 |
ENSRNOT00000058382
|
Nfatc1
|
nuclear factor of activated T-cells 1 |
chr12_+_9034308 | 9.36 |
ENSRNOT00000001248
|
Flt1
|
FMS-related tyrosine kinase 1 |
chr8_+_50310405 | 9.29 |
ENSRNOT00000073507
|
Sik3
|
SIK family kinase 3 |
chr4_-_67520356 | 9.29 |
ENSRNOT00000014604
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase |
chr7_-_142180794 | 9.21 |
ENSRNOT00000037447
|
Tfcp2
|
transcription factor CP2 |
chr15_-_43733182 | 9.19 |
ENSRNOT00000015318
|
Ppp2r2a
|
protein phosphatase 2, regulatory subunit B, alpha |
chr10_-_108150511 | 9.18 |
ENSRNOT00000073337
|
Cbx8
|
chromobox 8 |
chr19_-_25955371 | 9.11 |
ENSRNOT00000004042
ENSRNOT00000084123 |
Rad23a
|
RAD23 homolog A, nucleotide excision repair protein |
chr3_+_137618898 | 9.04 |
ENSRNOT00000007249
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr9_+_10428853 | 9.03 |
ENSRNOT00000074253
|
Lonp1
|
lon peptidase 1, mitochondrial |
chr7_-_44121130 | 8.91 |
ENSRNOT00000005706
|
Nts
|
neurotensin |
chr9_+_17817721 | 8.90 |
ENSRNOT00000086986
ENSRNOT00000026920 |
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1 |
chrX_-_82986051 | 8.89 |
ENSRNOT00000077587
|
Hdx
|
highly divergent homeobox |
chr4_-_51946715 | 8.83 |
ENSRNOT00000079130
|
Pot1
|
protection of telomeres 1 |
chr8_-_50228369 | 8.82 |
ENSRNOT00000024030
|
Tagln
|
transgelin |
chr10_+_37594578 | 8.76 |
ENSRNOT00000007676
|
Skp1
|
S-phase kinase-associated protein 1 |
chr7_+_144577465 | 8.67 |
ENSRNOT00000021647
|
Hoxc10
|
homeo box C10 |
chr4_-_113886994 | 8.64 |
ENSRNOT00000037333
|
Htra2
|
HtrA serine peptidase 2 |
chr6_-_60151420 | 8.50 |
ENSRNOT00000073910
|
Ifrd1
|
interferon-related developmental regulator 1 |
chr1_-_80666566 | 8.41 |
ENSRNOT00000082125
ENSRNOT00000025388 |
Nectin2
|
nectin cell adhesion molecule 2 |
chr3_-_72052990 | 8.37 |
ENSRNOT00000064009
ENSRNOT00000081400 |
Ctnnd1
|
catenin delta 1 |
chr7_-_75597276 | 8.24 |
ENSRNOT00000035628
|
Ywhaz
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr6_-_42473738 | 8.14 |
ENSRNOT00000033327
|
Kcnf1
|
potassium voltage-gated channel modifier subfamily F member 1 |
chr1_+_280423079 | 8.09 |
ENSRNOT00000011983
|
Slc18a2
|
solute carrier family 18 member A2 |
chr3_+_15463953 | 8.07 |
ENSRNOT00000033047
|
Mrrf
|
mitochondrial ribosome recycling factor |
chr19_-_34105610 | 7.99 |
ENSRNOT00000017347
|
Prmt9
|
protein arginine methyltransferase 9 |
chr1_+_73719005 | 7.97 |
ENSRNOT00000025110
|
Cdc42ep5
|
CDC42 effector protein 5 |
chr9_+_78968814 | 7.97 |
ENSRNOT00000057584
|
AABR07068042.1
|
|
chr1_-_178218761 | 7.95 |
ENSRNOT00000019199
|
Pth
|
parathyroid hormone |
chr14_-_86868598 | 7.91 |
ENSRNOT00000087212
|
Nacad
|
NAC alpha domain containing |
chr7_-_18612118 | 7.87 |
ENSRNOT00000078122
ENSRNOT00000010197 |
Rab11b
|
RAB11B, member RAS oncogene family |
chr3_+_148635775 | 7.83 |
ENSRNOT00000067261
|
Tm9sf4
|
transmembrane 9 superfamily member 4 |
chr10_-_90410569 | 7.82 |
ENSRNOT00000036112
|
Itga2b
|
integrin subunit alpha 2b |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.9 | 50.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) regulation of transforming growth factor-beta secretion(GO:2001201) |
13.7 | 54.8 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
12.8 | 12.8 | GO:1903210 | glomerular visceral epithelial cell apoptotic process(GO:1903210) |
11.2 | 33.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
10.4 | 72.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
9.7 | 38.8 | GO:0048319 | notochord formation(GO:0014028) axial mesoderm morphogenesis(GO:0048319) negative regulation of lymphangiogenesis(GO:1901491) |
7.9 | 47.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
7.6 | 30.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
7.5 | 22.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
7.4 | 22.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
7.0 | 7.0 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
6.8 | 27.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
6.5 | 25.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
6.0 | 24.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
6.0 | 24.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
5.8 | 11.7 | GO:0061354 | planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
5.8 | 17.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
5.4 | 16.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
5.4 | 16.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
5.3 | 32.0 | GO:0033227 | dsRNA transport(GO:0033227) |
5.1 | 15.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
5.0 | 64.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
5.0 | 14.9 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
4.6 | 41.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
4.5 | 13.6 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
4.5 | 35.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
4.5 | 13.4 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
4.3 | 30.4 | GO:0071460 | microspike assembly(GO:0030035) cellular response to cell-matrix adhesion(GO:0071460) |
4.2 | 12.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
4.1 | 12.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
4.1 | 16.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
4.0 | 11.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.9 | 30.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
3.7 | 36.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
3.6 | 21.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
3.6 | 14.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
3.6 | 21.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
3.4 | 10.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
3.2 | 28.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
3.2 | 12.6 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
3.1 | 15.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
3.1 | 18.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
3.1 | 42.8 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
3.0 | 12.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
3.0 | 20.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
3.0 | 8.9 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
2.9 | 8.8 | GO:0060383 | positive regulation of DNA strand elongation(GO:0060383) |
2.9 | 14.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
2.8 | 8.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
2.7 | 26.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
2.6 | 7.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
2.6 | 23.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
2.6 | 7.7 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
2.5 | 30.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
2.4 | 12.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
2.4 | 16.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.4 | 7.1 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) positive regulation of glycogen catabolic process(GO:0045819) |
2.3 | 9.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.3 | 32.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
2.2 | 15.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
2.1 | 6.4 | GO:0090135 | submandibular salivary gland formation(GO:0060661) positive regulation of hair follicle cell proliferation(GO:0071338) actin filament branching(GO:0090135) |
2.0 | 10.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
2.0 | 10.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.0 | 8.0 | GO:1900158 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
1.9 | 5.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.9 | 7.8 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.9 | 19.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.9 | 21.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.9 | 7.7 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
1.9 | 13.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.9 | 5.7 | GO:0031587 | lactate biosynthetic process from pyruvate(GO:0019244) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) regulation of intracellular mRNA localization(GO:1904580) |
1.9 | 13.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.9 | 53.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
1.8 | 5.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.8 | 9.0 | GO:0030070 | insulin processing(GO:0030070) |
1.8 | 8.9 | GO:0097332 | response to antipsychotic drug(GO:0097332) |
1.8 | 12.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.7 | 7.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.7 | 5.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
1.7 | 10.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.7 | 3.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.7 | 8.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.6 | 13.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.6 | 43.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.6 | 9.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
1.6 | 6.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.6 | 11.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
1.6 | 28.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.6 | 9.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.5 | 10.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.5 | 16.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.5 | 4.4 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
1.4 | 8.6 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
1.4 | 5.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.4 | 7.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.4 | 4.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.4 | 11.0 | GO:0015871 | choline transport(GO:0015871) |
1.4 | 61.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
1.4 | 27.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.3 | 5.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.3 | 18.4 | GO:0007614 | short-term memory(GO:0007614) |
1.3 | 3.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.2 | 15.9 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.2 | 12.0 | GO:0061042 | vascular wound healing(GO:0061042) |
1.2 | 15.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.2 | 22.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.1 | 22.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.1 | 6.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.1 | 10.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.1 | 12.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.1 | 5.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.1 | 14.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 12.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.1 | 4.4 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
1.1 | 16.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.0 | 3.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.0 | 11.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
1.0 | 9.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.0 | 6.7 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.9 | 10.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.9 | 8.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.9 | 13.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.9 | 3.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.9 | 5.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.8 | 6.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 15.7 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.8 | 7.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 32.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.8 | 7.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 3.1 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.8 | 16.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 12.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 12.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.7 | 28.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.7 | 6.3 | GO:0015866 | ADP transport(GO:0015866) |
0.7 | 9.0 | GO:0010044 | response to aluminum ion(GO:0010044) |
0.7 | 4.8 | GO:0042256 | mature ribosome assembly(GO:0042256) bone marrow development(GO:0048539) |
0.7 | 35.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.7 | 7.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.6 | 1.9 | GO:0021627 | muscle attachment(GO:0016203) olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
0.6 | 5.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.6 | 3.6 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.6 | 10.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.6 | 12.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 12.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 1.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.5 | 7.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.5 | 5.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 19.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.5 | 5.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.5 | 14.5 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.5 | 24.6 | GO:0009268 | response to pH(GO:0009268) |
0.5 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 6.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.5 | 10.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.4 | 21.5 | GO:0021762 | substantia nigra development(GO:0021762) |
0.4 | 37.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 2.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.4 | 5.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 9.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.4 | 8.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 21.9 | GO:0043278 | response to morphine(GO:0043278) |
0.4 | 3.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 2.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.4 | 6.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 12.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.4 | 5.3 | GO:0060746 | parental behavior(GO:0060746) |
0.4 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 5.2 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.3 | 24.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 18.0 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 4.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 16.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 5.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 4.7 | GO:0003094 | glomerular filtration(GO:0003094) |
0.3 | 8.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 9.3 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.3 | 6.5 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.3 | 2.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 2.6 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.3 | 2.0 | GO:0003360 | brainstem development(GO:0003360) |
0.3 | 3.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 3.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.3 | 2.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 13.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 8.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 5.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 2.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 10.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.2 | 4.3 | GO:0033327 | estrogen metabolic process(GO:0008210) Leydig cell differentiation(GO:0033327) |
0.2 | 4.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.6 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 8.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.2 | 19.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 16.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.2 | 2.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 6.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 2.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 7.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 10.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 31.6 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 1.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 4.9 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 2.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.1 | 9.7 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 26.6 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.1 | 9.4 | GO:0007613 | memory(GO:0007613) |
0.1 | 5.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 2.6 | GO:0060711 | anterior/posterior axis specification(GO:0009948) labyrinthine layer development(GO:0060711) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 4.3 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 15.6 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.1 | 9.7 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 40.3 | GO:0006412 | translation(GO:0006412) |
0.1 | 4.7 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 15.1 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 1.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 16.9 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 2.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 11.3 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 1.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 8.1 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 1.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 3.7 | GO:0045216 | cell-cell junction organization(GO:0045216) |
0.0 | 0.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 15.4 | GO:0006952 | defense response(GO:0006952) |
0.0 | 1.3 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.4 | 55.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
7.6 | 30.4 | GO:0044393 | microspike(GO:0044393) |
6.3 | 50.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
5.2 | 25.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
4.3 | 34.1 | GO:0005869 | dynactin complex(GO:0005869) |
4.2 | 21.1 | GO:0035976 | AP1 complex(GO:0035976) |
3.7 | 11.0 | GO:0005745 | m-AAA complex(GO:0005745) |
3.4 | 10.1 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
3.2 | 9.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
3.0 | 54.8 | GO:0071437 | invadopodium(GO:0071437) |
2.9 | 11.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.8 | 19.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.7 | 13.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.7 | 15.9 | GO:0044308 | axonal spine(GO:0044308) |
2.5 | 40.5 | GO:0031045 | dense core granule(GO:0031045) |
2.5 | 22.3 | GO:0042583 | chromaffin granule(GO:0042583) |
2.3 | 25.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
2.2 | 13.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
2.2 | 21.9 | GO:0070652 | HAUS complex(GO:0070652) |
2.2 | 10.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.1 | 27.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.0 | 15.8 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
1.9 | 5.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.8 | 16.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.8 | 8.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.7 | 5.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.7 | 13.3 | GO:0032584 | growth cone membrane(GO:0032584) |
1.6 | 20.2 | GO:0031143 | pseudopodium(GO:0031143) |
1.5 | 16.8 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 10.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.1 | 15.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 16.1 | GO:0044754 | autolysosome(GO:0044754) |
1.1 | 9.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 20.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 8.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.9 | 22.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 8.8 | GO:0070187 | telosome(GO:0070187) |
0.9 | 12.2 | GO:0060091 | kinocilium(GO:0060091) |
0.9 | 24.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 17.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.8 | 7.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 9.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.8 | 2.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
0.8 | 20.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.7 | 5.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.7 | 8.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 5.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 3.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 9.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 67.7 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 18.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 52.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 12.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 15.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 9.7 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 42.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.6 | 40.1 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 16.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 15.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 4.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 25.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 5.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 42.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.5 | 1.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 4.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.4 | 23.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 12.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 7.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 2.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 6.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 7.9 | GO:0030666 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.3 | 43.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.3 | 77.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 3.6 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 7.8 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 13.9 | GO:0005844 | polysome(GO:0005844) |
0.3 | 40.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 31.8 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 3.1 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 51.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 4.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 12.4 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 10.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 34.9 | GO:0034702 | ion channel complex(GO:0034702) |
0.2 | 5.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 7.1 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 2.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 2.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 10.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 16.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 3.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 89.6 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 3.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 22.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 20.1 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 33.9 | GO:0005768 | endosome(GO:0005768) |
0.1 | 9.9 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 147.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 2.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 54.1 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 8.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 10.5 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 131.7 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 7.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 198.2 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 6.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 7.5 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 43.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 22.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 7.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 76.3 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 4.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 4.9 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 150.8 | GO:0016020 | membrane(GO:0016020) |
0.0 | 1.1 | GO:0000793 | condensed chromosome(GO:0000793) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.3 | 42.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
7.2 | 50.7 | GO:0045340 | mercury ion binding(GO:0045340) |
6.4 | 32.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
5.1 | 15.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
4.8 | 24.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
4.6 | 18.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.2 | 12.7 | GO:0052743 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) inositol tetrakisphosphate phosphatase activity(GO:0052743) |
4.1 | 16.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
3.9 | 15.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
3.6 | 14.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
3.6 | 21.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
3.3 | 16.6 | GO:0032564 | dATP binding(GO:0032564) |
3.2 | 12.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
3.1 | 21.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
3.0 | 60.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
2.9 | 11.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
2.9 | 14.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.8 | 19.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.7 | 27.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.7 | 8.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.7 | 13.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.6 | 21.2 | GO:0030957 | Tat protein binding(GO:0030957) |
2.6 | 55.4 | GO:0031996 | thioesterase binding(GO:0031996) |
2.6 | 36.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.6 | 20.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.6 | 62.3 | GO:0005112 | Notch binding(GO:0005112) |
2.6 | 35.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.5 | 12.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
2.5 | 64.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.4 | 9.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
2.4 | 7.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.3 | 25.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
2.3 | 9.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
2.2 | 8.8 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
2.2 | 11.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.1 | 6.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
2.1 | 6.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
2.1 | 8.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.0 | 12.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.0 | 10.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.0 | 26.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.0 | 15.7 | GO:0031419 | cobalamin binding(GO:0031419) |
1.8 | 37.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.7 | 78.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.7 | 5.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
1.7 | 10.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.6 | 14.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.6 | 16.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.6 | 15.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
1.5 | 6.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.5 | 10.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.5 | 10.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.5 | 4.4 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.4 | 18.6 | GO:1990405 | protein antigen binding(GO:1990405) |
1.4 | 11.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.4 | 30.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.3 | 7.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.3 | 5.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.2 | 32.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
1.2 | 29.5 | GO:0031489 | myosin V binding(GO:0031489) |
1.2 | 39.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.2 | 9.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 19.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.1 | 27.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.0 | 7.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 3.1 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 14.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.9 | 5.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 20.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.9 | 17.5 | GO:0005537 | mannose binding(GO:0005537) |
0.9 | 22.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.8 | 3.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.8 | 9.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.8 | 13.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.8 | 10.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.8 | 2.3 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.8 | 5.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.8 | 9.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 54.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.7 | 15.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 5.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 6.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.7 | 4.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.6 | 13.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.6 | 13.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 16.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 10.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 15.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.5 | 13.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 9.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 8.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 18.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 74.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 5.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 24.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 14.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 10.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 4.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 3.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.5 | 12.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 13.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 14.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 26.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 7.3 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 4.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 5.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 30.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 8.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 15.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 10.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 32.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 10.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 13.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 39.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.3 | 31.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 16.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.3 | 10.1 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 21.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.3 | 7.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 1.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 10.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 17.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 5.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 2.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 3.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 11.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 10.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 6.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 4.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 12.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 13.3 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 28.1 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 53.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 7.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 43.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 51.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.9 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.2 | 59.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 70.1 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 16.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 4.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 3.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 20.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 7.0 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 18.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 3.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 3.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 14.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 10.4 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 69.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 13.2 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 17.2 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 17.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 4.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 8.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 10.4 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 9.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 4.8 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 2.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 15.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 2.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 4.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 21.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 3.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 10.8 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 0.7 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 1.1 | GO:0008565 | protein transporter activity(GO:0008565) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 103.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.4 | 50.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.2 | 46.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.0 | 74.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.5 | 22.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.4 | 46.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.3 | 30.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.2 | 37.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.0 | 9.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.0 | 22.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 39.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.9 | 18.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 32.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.8 | 12.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 10.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 14.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 91.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.7 | 15.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 37.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.6 | 8.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 28.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.5 | 22.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 4.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 7.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 20.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 10.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 8.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 6.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 5.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 4.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 9.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 3.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 7.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 10.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 10.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 6.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 8.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 13.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 10.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 67.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
3.1 | 55.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.8 | 16.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.4 | 26.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.1 | 18.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.0 | 27.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
2.0 | 55.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
2.0 | 29.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.4 | 14.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.4 | 24.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 17.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 15.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 12.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.8 | 22.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.8 | 42.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.8 | 9.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 14.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.7 | 8.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 16.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.7 | 10.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.6 | 10.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.6 | 13.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 10.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 9.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 20.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 12.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 13.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 6.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 45.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 13.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 16.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 10.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 78.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.4 | 10.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 9.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 21.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 17.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 12.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 4.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 8.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 4.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 14.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 30.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.2 | 15.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 5.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 5.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 5.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 4.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 7.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 14.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 5.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 15.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 3.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 23.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 8.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 3.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |